Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
出版年份 2017 全文链接
标题
Azacitidine for Front-Line Therapy of Patients with AML: Reproducible Efficacy Established by Direct Comparison of International Phase 3 Trial Data with Registry Data from the Austrian Azacitidine Registry of the AGMT Study Group
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 18, Issue 2, Pages 415
出版商
MDPI AG
发表日期
2017-02-15
DOI
10.3390/ijms18020415
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Participation of the Elderly Population in Clinical Trials: Barriers and Solutions
- (2017) Aaron C. Denson et al. Cancer Control
- Disease-related costs of care and survival among Medicare-enrolled patients with myelodysplastic syndromes
- (2016) Amer M. Zeidan et al. CANCER
- Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications
- (2016) Lisa Pleyer et al. Journal of Hematology & Oncology
- Population-based analyses among 184 patients diagnosed with large granular lymphocyte leukemia in the Netherlands between 2001 and 2013
- (2016) A G Dinmohamed et al. LEUKEMIA
- Genomic Classification and Prognosis in Acute Myeloid Leukemia
- (2016) Elli Papaemmanuil et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Role of Azacitidine in the Treatment of Elderly Patients with Acute Myeloid Leukemia: Results of a Retrospective Multicenter Study
- (2016) Anıl Tombak et al. Turkish Journal of Hematology
- Improved outcome in acute myeloid leukemia patients enrolled in clinical trials: A national population-based cohort study of Danish intensive chemotherapy patients
- (2016) Lene Sofie Granfeldt Østgård et al. Oncotarget
- Characterization and prognostic features of secondary acute myeloid leukemia in a population-based setting: A report from the Swedish Acute Leukemia Registry
- (2015) Erik Hulegårdh et al. AMERICAN JOURNAL OF HEMATOLOGY
- International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts
- (2015) H. Dombret et al. BLOOD
- Phase III Open-Label Randomized Study of Cytarabine in Combination With Amonafide L-Malate or Daunorubicin As Induction Therapy for Patients With Secondary Acute Myeloid Leukemia
- (2015) Richard M. Stone et al. JOURNAL OF CLINICAL ONCOLOGY
- Effectiveness of azacitidine for the treatment of higher-risk myelodysplastic syndromes in daily practice: results from the Dutch population-based PHAROS MDS registry
- (2015) A G Dinmohamed et al. LEUKEMIA
- Effectiveness of azacitidine in unselected high-risk myelodysplastic syndromes: results from the Spanish registry
- (2015) T Bernal et al. LEUKEMIA
- The use of medical claims to assess incidence, diagnostic procedures and initial treatment of myelodysplastic syndromes and chronic myelomonocytic leukemia in the Netherlands
- (2015) Avinash G. Dinmohamed et al. LEUKEMIA RESEARCH
- Azacitidine frontline therapy for unfit acute myeloid leukemia patients: Clinical use and outcome prediction
- (2015) F. Ramos et al. LEUKEMIA RESEARCH
- Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2014) Lisa Pleyer et al. ANNALS OF HEMATOLOGY
- Azacitidine in CMML: Matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival
- (2014) Lisa Pleyer et al. LEUKEMIA RESEARCH
- Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience
- (2014) V Lazarevic et al. Blood Cancer Journal
- Azacitidine in untreated acute myeloid leukemia: A report on 149 patients
- (2013) Sylvain Thépot et al. AMERICAN JOURNAL OF HEMATOLOGY
- Azacitidine in patients with WHO-defined AML – Results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group
- (2013) Lisa Pleyer et al. Journal of Hematology & Oncology
- Data quality in the Danish National Acute Leukemia Registry: a hematological data resource
- (2013) Lene Sofie Granfeldt Østgård et al. Clinical Epidemiology
- Acute myeloid leukemia in the real world: why population-based registries are needed
- (2012) G. Juliusson et al. BLOOD
- Survival for older patients with acute myeloid leukemia: a population-based study
- (2012) B. Oran et al. HAEMATOLOGICA
- 101 Age- and comorbidity-specific evaluation of azacitidine treatment, response and overall survival in 184 patients in the Austrian Azacitidine Registry
- (2011) L. Pleyer et al. LEUKEMIA RESEARCH
- 100 Overall survival data of patients with MDS, AML and CMML from the Austrian Azacitidine Registry of 184 consecutive patients
- (2011) L. Pleyer et al. LEUKEMIA RESEARCH
- Pattern of hypomethylating agents use among elderly patients with myelodysplastic syndromes
- (2010) Rong Wang et al. LEUKEMIA RESEARCH
- Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
- (2009) Pierre Fenaux et al. JOURNAL OF CLINICAL ONCOLOGY
- Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study
- (2009) Pierre Fenaux et al. LANCET ONCOLOGY
- Acute Myelogenous Leukemia in Older Adults
- (2009) H. D. Klepin et al. ONCOLOGIST
- Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry
- (2008) G. Juliusson et al. BLOOD
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation